FENC compared with NRXS: revenue, margins and what each company keeps, and the suppliers and customers both name

FENCFennec Pharmaceuticals Inc.

Mkt capRevenueRevenue

NRXSNeuraxis, Inc

Mkt capRevenueRevenue

Compare

FENCFennec Pharmaceuticals Inc.

NRXSNeuraxis, Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

FENC

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q1 FY26±48.6%▲+2.49%×0.05

Mar 11 '25±30.1%▲+4.75%×0.16

Mar 26 '24±36.6%▼−1.00%×0.03

Nov 7 '23±32.8%▲+2.51%×0.08

NRXS

No earnings history for NRXS.

= impliedFENC realized, solidNRXS realized, hatchedOne scale, both sides: full bar = 49%× = |realized| ÷ impliedSource: market data

FENCFennec Pharmaceuticals Inc.

9.98▲+6.28%· post 9.98

Mkt cap$344.0MRevenue$18MQ2 FY26Revenue$45MFY25

NRXSNeuraxis, Inc

6.03▼−1.31%· post 6.33

ClosedNov 6 '26

Mkt cap$78.4MRevenue$2MQ2 FY26Revenue$4MFY25

Compare

ClosedNov 6 '26

FENCFennec Pharmaceuticals Inc.

NRXSNeuraxis, Inc

9.98▲+6.28%post 9.98

Price

6.03▼−1.31%post 6.33

$344.0M

Mkt cap

$78.4M

Q2 FY26$18M

Revenue

$2MQ2 FY26

FY25$45M

Revenue

$4MFY25

FENC9.98▲+6.28%vsNRXS6.03▼−1.31%ClosedNov 6 '26